Phenotype-driven molecular autopsy for sudden cardiac death

F Cann, M Corbett, D O'Sullivan, S. Tennant, H. Hailey, J H K Grieve, P Broadhurst, R Rankin, J C S Dean

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A phenotype driven approach to molecular autopsy based in a multidisciplinary team comprising clinical and laboratory genetics, forensic medicine and cardiology is described. Over a 13 year period, molecular autopsy was undertaken in 96 sudden cardiac death cases. 46 cases aged 1-40 years had normal hearts and suspected arrhythmic death. 7 (15%) had likely pathogenic variants in ion channelopathy genes (KCNQ1 (1), KCNH2 (4), SCN5A (1), RyR2(1)). 50 cases aged between 2 and 67 had a cardiomyopathy. 25 had Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), 10 Dilated Cardiomyopathy (DCM) and 15 Hypertrophic Cardiomyopathy (HCM). Likely pathogenic variants were found in 3 ARVC cases (12%) in PKP2, DSC2 or DSP, 2 DCM cases (20%) in MYH7, and 4 HCM cases (27%) in MYBPC3 (3) or MYH7 (1). Uptake of cascade screening in relatives was higher when a molecular diagnosis was made at autopsy. In 3 families, variants previously published as pathogenic were detected, but clinical investigation revealed no abnormalities in carrier relatives. With a conservative approach to defining pathogenicity of sequence variants incorporating family phenotype information and population genomic data, a molecular diagnosis was made in 15% of sudden arrhythmic deaths and 18% of cardiomyopathy deaths.
Original languageEnglish
Pages (from-to)22-29
Number of pages8
JournalClinical Genetics
Volume91
Issue number1
Early online date11 May 2016
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Sudden Cardiac Death
Autopsy
Hypertrophic Cardiomyopathy
Dilated Cardiomyopathy
Phenotype
Cardiomyopathies
Channelopathies
Metagenomics
Ryanodine Receptor Calcium Release Channel
Forensic Medicine
Sudden Death
Cardiology
Virulence
Ions
Genes

Keywords

  • clinical phenotyping
  • genetic testing
  • molecular autopsy
  • sudden death

Cite this

Cann, F., Corbett, M., O'Sullivan, D., Tennant, S., Hailey, H., Grieve, J. H. K., ... Dean, J. C. S. (2017). Phenotype-driven molecular autopsy for sudden cardiac death. Clinical Genetics, 91(1), 22-29. https://doi.org/10.1111/cge.12778

Phenotype-driven molecular autopsy for sudden cardiac death. / Cann, F; Corbett, M; O'Sullivan, D; Tennant, S.; Hailey, H.; Grieve, J H K; Broadhurst, P; Rankin, R; Dean, J C S.

In: Clinical Genetics, Vol. 91, No. 1, 01.01.2017, p. 22-29.

Research output: Contribution to journalArticle

Cann, F, Corbett, M, O'Sullivan, D, Tennant, S, Hailey, H, Grieve, JHK, Broadhurst, P, Rankin, R & Dean, JCS 2017, 'Phenotype-driven molecular autopsy for sudden cardiac death', Clinical Genetics, vol. 91, no. 1, pp. 22-29. https://doi.org/10.1111/cge.12778
Cann F, Corbett M, O'Sullivan D, Tennant S, Hailey H, Grieve JHK et al. Phenotype-driven molecular autopsy for sudden cardiac death. Clinical Genetics. 2017 Jan 1;91(1):22-29. https://doi.org/10.1111/cge.12778
Cann, F ; Corbett, M ; O'Sullivan, D ; Tennant, S. ; Hailey, H. ; Grieve, J H K ; Broadhurst, P ; Rankin, R ; Dean, J C S. / Phenotype-driven molecular autopsy for sudden cardiac death. In: Clinical Genetics. 2017 ; Vol. 91, No. 1. pp. 22-29.
@article{c590fba4174a433c8b6564b9a05a74ca,
title = "Phenotype-driven molecular autopsy for sudden cardiac death",
abstract = "A phenotype driven approach to molecular autopsy based in a multidisciplinary team comprising clinical and laboratory genetics, forensic medicine and cardiology is described. Over a 13 year period, molecular autopsy was undertaken in 96 sudden cardiac death cases. 46 cases aged 1-40 years had normal hearts and suspected arrhythmic death. 7 (15{\%}) had likely pathogenic variants in ion channelopathy genes (KCNQ1 (1), KCNH2 (4), SCN5A (1), RyR2(1)). 50 cases aged between 2 and 67 had a cardiomyopathy. 25 had Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), 10 Dilated Cardiomyopathy (DCM) and 15 Hypertrophic Cardiomyopathy (HCM). Likely pathogenic variants were found in 3 ARVC cases (12{\%}) in PKP2, DSC2 or DSP, 2 DCM cases (20{\%}) in MYH7, and 4 HCM cases (27{\%}) in MYBPC3 (3) or MYH7 (1). Uptake of cascade screening in relatives was higher when a molecular diagnosis was made at autopsy. In 3 families, variants previously published as pathogenic were detected, but clinical investigation revealed no abnormalities in carrier relatives. With a conservative approach to defining pathogenicity of sequence variants incorporating family phenotype information and population genomic data, a molecular diagnosis was made in 15{\%} of sudden arrhythmic deaths and 18{\%} of cardiomyopathy deaths.",
keywords = "clinical phenotyping, genetic testing, molecular autopsy, sudden death",
author = "F Cann and M Corbett and D O'Sullivan and S. Tennant and H. Hailey and Grieve, {J H K} and P Broadhurst and R Rankin and Dean, {J C S}",
note = "Acknowledgements We are grateful to the Scottish Genetics Consortium Laboratories in Edinburgh and Glasgow for their analysis of the sarcomere genes and LMNA, respectively.",
year = "2017",
month = "1",
day = "1",
doi = "10.1111/cge.12778",
language = "English",
volume = "91",
pages = "22--29",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Phenotype-driven molecular autopsy for sudden cardiac death

AU - Cann, F

AU - Corbett, M

AU - O'Sullivan, D

AU - Tennant, S.

AU - Hailey, H.

AU - Grieve, J H K

AU - Broadhurst, P

AU - Rankin, R

AU - Dean, J C S

N1 - Acknowledgements We are grateful to the Scottish Genetics Consortium Laboratories in Edinburgh and Glasgow for their analysis of the sarcomere genes and LMNA, respectively.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - A phenotype driven approach to molecular autopsy based in a multidisciplinary team comprising clinical and laboratory genetics, forensic medicine and cardiology is described. Over a 13 year period, molecular autopsy was undertaken in 96 sudden cardiac death cases. 46 cases aged 1-40 years had normal hearts and suspected arrhythmic death. 7 (15%) had likely pathogenic variants in ion channelopathy genes (KCNQ1 (1), KCNH2 (4), SCN5A (1), RyR2(1)). 50 cases aged between 2 and 67 had a cardiomyopathy. 25 had Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), 10 Dilated Cardiomyopathy (DCM) and 15 Hypertrophic Cardiomyopathy (HCM). Likely pathogenic variants were found in 3 ARVC cases (12%) in PKP2, DSC2 or DSP, 2 DCM cases (20%) in MYH7, and 4 HCM cases (27%) in MYBPC3 (3) or MYH7 (1). Uptake of cascade screening in relatives was higher when a molecular diagnosis was made at autopsy. In 3 families, variants previously published as pathogenic were detected, but clinical investigation revealed no abnormalities in carrier relatives. With a conservative approach to defining pathogenicity of sequence variants incorporating family phenotype information and population genomic data, a molecular diagnosis was made in 15% of sudden arrhythmic deaths and 18% of cardiomyopathy deaths.

AB - A phenotype driven approach to molecular autopsy based in a multidisciplinary team comprising clinical and laboratory genetics, forensic medicine and cardiology is described. Over a 13 year period, molecular autopsy was undertaken in 96 sudden cardiac death cases. 46 cases aged 1-40 years had normal hearts and suspected arrhythmic death. 7 (15%) had likely pathogenic variants in ion channelopathy genes (KCNQ1 (1), KCNH2 (4), SCN5A (1), RyR2(1)). 50 cases aged between 2 and 67 had a cardiomyopathy. 25 had Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), 10 Dilated Cardiomyopathy (DCM) and 15 Hypertrophic Cardiomyopathy (HCM). Likely pathogenic variants were found in 3 ARVC cases (12%) in PKP2, DSC2 or DSP, 2 DCM cases (20%) in MYH7, and 4 HCM cases (27%) in MYBPC3 (3) or MYH7 (1). Uptake of cascade screening in relatives was higher when a molecular diagnosis was made at autopsy. In 3 families, variants previously published as pathogenic were detected, but clinical investigation revealed no abnormalities in carrier relatives. With a conservative approach to defining pathogenicity of sequence variants incorporating family phenotype information and population genomic data, a molecular diagnosis was made in 15% of sudden arrhythmic deaths and 18% of cardiomyopathy deaths.

KW - clinical phenotyping

KW - genetic testing

KW - molecular autopsy

KW - sudden death

U2 - 10.1111/cge.12778

DO - 10.1111/cge.12778

M3 - Article

VL - 91

SP - 22

EP - 29

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 1

ER -